SCHEMBL17675164

SCHEMBL17675164

CCCCn1cc(Cc2c(C)cc(C)cc2C)c(C(=O)O)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.36
MAPT P10636 3/20 0.35
LMNA P02545 2/20 0.35
TP53 P04637 2/20 0.35
KDM4E B2RXH2 2/20 0.34
NR1I2 O75469 1/20 0.33
ALDH1A1 P00352 2/20 0.33
TLR8 Q9NR97 1/20 0.33
TLR7 Q9NYK1 1/20 0.33
TYR P14679 1/20 0.33
POLB P06746 1/20 0.32
TSHR P16473 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
SSTR5 P35346 1/20 0.32
IRAK4 Q9NWZ3 1/20 0.32
PTGER1 P34995 2/20 0.31
HCAR3 P49019 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18694863 0.77 KDR (0.39) HCAR2L3MBTL1HCAR3
SCHEMBL17646571 0.75 KDM4E (0.39) MAPTTP53KDM4EALDH1A1SMN1; SMN2
SCHEMBL23114181 0.71 HCAR2 (0.39) HCAR2TLR8TLR7L3MBTL1MEN1
SCHEMBL10968801 0.69 EGLN1 (0.38) HCAR2
SCHEMBL28206409 0.68 CYP11B1 (0.33) MAPTLMNATP53KDM4EALDH1A1
SCHEMBL28784085 0.67 KDR (0.44) HCAR2TLR8TLR7L3MBTL1HCAR3
SCHEMBL28851116 0.65 PTGER1 (0.39) HCAR2MAPTKDM4EALDH1A1TSHR
SCHEMBL10715676 0.65 CNR2 (0.38) HCAR2L3MBTL1MEN1KMT2A
SCHEMBL17675165 0.64 LMNA (0.46) LMNAKDM4EALDH1A1POLBTSHR
SCHEMBL23401237 0.64 TYR (0.37) TLR8TLR7TYRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3203840-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2017-08-16 EP disclosed
WO-2016057572-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MILLER MARK THOMAS (US) 2016-04-14 WO disclosed